PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
The present application relates to a pyrimidine derivative, and a preparation method therefor and the use thereof. The pyrimidine derivative is selected from a compound represented by general formula (I) or a tautomer, enantiomer, diastereomer, mesoisomer, racemate or mixture thereof, or a pharmaceutically acceptable salt or prodrug thereof. The pyrimidine derivative exhibits excellent CDK-inhibiting effects..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 06. Jan. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
YU QIANG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-01-06, Last update posted on www.tib.eu: 2023-08-16, Last updated: 2023-08-18 |
|---|
| Patentnummer: |
WO2022002270 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA015831507 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA015831507 | ||
| 003 | DE-627 | ||
| 005 | 20230818085228.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA015831507 | ||
| 035 | |a (EPA)WO2022002270 | ||
| 035 | |a (EPA)79013032 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a YU QIANG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-01-06, Last update posted on www.tib.eu: 2023-08-16, Last updated: 2023-08-18 | ||
| 520 | |a The present application relates to a pyrimidine derivative, and a preparation method therefor and the use thereof. The pyrimidine derivative is selected from a compound represented by general formula (I) or a tautomer, enantiomer, diastereomer, mesoisomer, racemate or mixture thereof, or a pharmaceutically acceptable salt or prodrug thereof. The pyrimidine derivative exhibits excellent CDK-inhibiting effects. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a DING JUPING |4 aut | |
| 700 | 0 | |a TANG MULIN |4 aut | |
| 700 | 0 | |a HAO YAN |4 aut | |
| 700 | 0 | |a LU QIN |4 aut | |
| 700 | 0 | |a QIAN SHEN |4 aut | |
| 700 | 0 | |a TIAN XUSHENG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 06. Jan. |
| 773 | 1 | 8 | |g year:2022 |g day:06 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/79013032/publication/WO2022002270A1?q=WO2022002270 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2022 |b 06 |c 01 |
| 951 | |a AR | ||
| 952 | |j 2022 |b 06 |c 01 | ||